Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

microRNA expression profile and differentially-expressed genes in prolactinomas following bromocriptine treatment

17 Feb 2012

Abstract excerpt

Little is known about the function of microRNAs in prolactinomas treated with bromocriptine. The aim of the study was to explore the microRNAs associated with bromocriptine-treated prolactinomas. Six prolactinoma samples were selected according to whether they received bromocriptine treatment or not before microsurgery, and microRNA expression profiles of bromocriptine-treated and untreated prolactinomas were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ovarian cancer diagnosis and treatment
Share to Pituitary Gland Disorders and Treatments
Share to TGF-β signaling in diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22366961
DOI: 10.3892/or.2012.1690

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

microRNA expression profile and differentially-expressed genes in prolactinomas following bromocriptine treatmentPMID 22366961Read ↗

MicroRNAs in pituitary tumors.Semantic proximity Read ↗

Next-generation sequencing of microRNAs reveals a unique expression pattern in different types of pituitary adenomasSemantic proximity Read ↗

MicroRNAs and Target Genes in Pituitary AdenomasSemantic proximity Read ↗

MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behaviorSemantic proximity Read ↗

MiRNAs as Noninvasive Biomarkers and Therapeutic Agents of Pituitary AdenomasSemantic proximity Read ↗

Molecular pathogenesis of human prolactinomas identified by gene expression profiling, RT-qPCR, and proteomic analysesSemantic proximity Read ↗

Tumor suppressor miR-145-5p sensitizes prolactinoma to bromocriptine by downregulating TPT1Semantic proximity Read ↗

The experimental study of miRNA in pituitary adenomas.Semantic proximity Read ↗

Advancements in the study of miRNA regulation during the cell cycle in human pituitary adenomasSemantic proximity Read ↗

Differential expression of microRNAs in GH-secreting pituitary adenomas.Semantic proximity Read ↗

Curcumin Sensitizes Prolactinoma to Bromocriptine by Activating the ERK/EGR1 and Inhibiting AKT/GSK3β Signaling PathwaySemantic proximity Read ↗

Association of prolactin receptor (PRLR) variants with prolactinomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.